News

Izotropic Receives Response From U.S. FDA

Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the…

2 years ago

Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference

ANN ARBOR, MI / ACCESSWIRE / January 30, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

2 years ago

Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia

– No differentiation syndrome events reported – – 100% CR rate with 7+3 in newly diagnosed NPM1-m and KMT2A-r AML…

2 years ago

Breckenridge Distillery and Breckenridge Brewery Announce Fourth Edition of Sexy Motor Oil Whiskey and New Sexy Motor Oil Beer

Limited-Edition Sexy Motor Oil Whiskey and Beer Collaboration Available Exclusively at Breckenridge Distillery and Breckenridge Brewery Locations in Colorado Starting…

2 years ago

Expanding Capabilities for Clients: Olon to Open New High Potency API Suite in US

MILAN, Italy, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Olon Group announces the construction of a cutting-edge High Potency API suite.…

2 years ago

CorVel Announces Revenues and Earnings

FORT WORTH, Texas, Jan. 30, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended…

2 years ago

COUR Pharmaceuticals Secures $105 Million in Series A Financing Co-Led by Lumira Ventures and Alpha Wave Ventures

Funds will be used to support the advancement of COUR’s Myasthenia Gravis (MG) and Type 1 Diabetes (T1D) product candidates…

2 years ago

The Ensign Group Schedules Year-End 2023 Earnings Call for Friday, February 2, 2024

SAN JUAN CAPISTRANO, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group…

2 years ago

RevoluGen Demonstrates Superior Automated Magnetic Bead-Based HMW-DNA Extraction with its Fire Monkey Chemistry Under Collaboration with LGC Biosearch Technologies

HADFIELD, United Kingdom, Jan. 30, 2024 (GLOBE NEWSWIRE) -- UK genomics company, RevoluGen Ltd., has demonstrated a new protocol for…

2 years ago

High-Performance Computing, simulations and AI: Qubit Pharmaceuticals, Institut Curie and the University of Bordeaux team up to advance the development of novel cancer therapies

                Press Release High-Performance Computing, simulations and AI: Qubit Pharmaceuticals, Institut Curie and the University of Bordeaux team…

2 years ago